The groundbreaking rise of Viagra has consistently remained a symbol of pharmaceutical success, however its future within the broader market now presents questions about potential gains. Copycat versions are eroding market share, prompting anxieties that betting on companies heavily reliant to Viagra's former standing could be a speculative move ,